NRX Pharmaceuticals, Inc. — SC 13D Filings
5 SC 13D filings on record
This page lists all SC 13D filings submitted to the SEC by NRX Pharmaceuticals, Inc. (NRXPW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NRX Pharmaceuticals, Inc. has filed 5 SC 13D documents with the SEC since 2017. To view all SEC filings by NRX Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
424B5
424B7
425
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D | — | 0001493152-22-025758 | Sep 13, 2022 | — |
| SC 13D | — | 0000921895-22-001894 | Jun 3, 2022 | — |
| SC 13D | SCHEDULE 13D | 0000950142-21-001848 | Jun 3, 2021 | — |
| SC 13D | SCHEDULE 13D | 0001213900-18-016512 | Nov 26, 2018 | — |
| SC 13D | FORM SC 13D | 0001654954-17-011843 | Dec 22, 2017 | — |